𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Chromatin Modifications as Targets for New Anticancer Drugs

✍ Scribed by Stefan Schäfer; Manfred Jung

Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
150 KB
Volume
338
Category
Article
ISSN
0365-6233

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Farnesyltransferase as a target for anti
Farnesyltransferase as a target for anticancer drug design
✍ Yimin Qian; Saïd M. Sebti; Andrew D. Hamilton 📂 Article 📅 1997 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 233 KB 👁 2 views

The currently understood function for Ras in signal transduction is in mediating the transmission of signals from external growth factors to the cell nucleus. Mutated forms of this GTP-binding protein are found in 30% of human cancers with particularly high prevalence in colon and pancreatic carcino

ROS receptor tyrosine kinase: a new pote
ROS receptor tyrosine kinase: a new potential target for anticancer drugs
✍ Ibrahim Mustafa El-Deeb; Kyung Ho Yoo; So Ha Lee 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 233 KB

ROS kinase is one of the last two remaining orphan receptor tyrosine kinases with an as yet unidentified ligand. The normal functions of human ROS kinase in different body tissues have not been fully identified so far. However, the ectopic expression, as well as the production of variable mutant for

Anticancer drugs that target metabolism:
Anticancer drugs that target metabolism: Is dichloroacetate the new paradigm?
✍ Ioanna Papandreou; Tereza Goliasova; Nicholas C. Denko 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 500 KB

## Abstract Recent findings in the fields of oncogenic regulation of metabolism, mitochondrial function and macromolecular synthesis have brought tumor metabolism and the Warburg effect back into the scientific limelight. A number of metabolic pathways that seem to be important for tumor growth are